Control of microglial neurotoxicity by the fractalkine receptor (Q28513748)

25 January 2017

title

Control of microglial neurotoxicity by the fractalkine receptor (English)

1 reference

25 January 2017

0 references

1 reference

1 reference

16

Richard M. Ransohoff

1 reference

25 January 2017

15

Dan R. Littman

1 reference

25 January 2017

Astrid E. Cardona

1

1 reference

25 January 2017

Erik P. Pioro

2

1 reference

25 January 2017

Margaret E. Sasse

3

1 reference

25 January 2017

Volodymyr Kostenko

4

1 reference

25 January 2017

Sandra M. Cardona

5

1 reference

25 January 2017

Ineke M. Dijkstra

6

1 reference

25 January 2017

Deren Huang

7

1 reference

25 January 2017

Grahame Kidd

8

1 reference

25 January 2017

Stephen Dombrowski

9

1 reference

25 January 2017

RanJan Dutta

10

1 reference

25 January 2017

Jar-Chi Lee

11

1 reference

25 January 2017

Donald N. Cook

12

1 reference

25 January 2017

Steffen Jung

13

1 reference

25 January 2017

Sergio A. Lira

14

1 reference

25 January 2017

language of work or name

English

0 references

publication date

1 July 2006

1 reference

25 January 2017

1 reference

25 January 2017

volume

9

1 reference

25 January 2017

issue

7

1 reference

25 January 2017

page(s)

917–924

1 reference

Role for neuronally derived fractalkine in mediating interactions between neurons and CX3CR1-expressing microglia

25 January 2017

cites work

1 reference

7 January 2021

Generation and analysis of mice lacking the chemokine fractalkine

1 reference

7 January 2021

CX3CR1-mediated dendritic cell access to the intestinal lumen and bacterial clearance

1 reference

7 January 2021

Blood monocytes consist of two principal subsets with distinct migratory properties

1 reference

7 January 2021

Analysis of fractalkine receptor CX(3)CR1 function by targeted deletion and green fluorescent protein reporter gene insertion

1 reference

7 January 2021

Targeted deletion of CX(3)CR1 reveals a role for fractalkine in cardiac allograft rejection

1 reference

7 January 2021

The neuronal chemokine CX3CL1/fractalkine selectively recruits NK cells that modify experimental autoimmune encephalomyelitis within the central nervous system

1 reference

7 January 2021

The chemokine fractalkine inhibits Fas-mediated cell death of brain microglia

1 reference

7 January 2021

ATP mediates rapid microglial response to local brain injury in vivo

1 reference

7 January 2021

Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo

1 reference

7 January 2021

Microglia: a sensor for pathological events in the CNS

1 reference

7 January 2021

Brain and bone damage in KARAP/DAP12 loss-of-function mice correlate with alterations in microglia and osteoclast lineages.

1 reference

7 January 2021

Clearance of apoptotic neurons without inflammation by microglial triggering receptor expressed on myeloid cells-2.

1 reference

7 January 2021

Microglia-specific localisation of a novel calcium binding protein, Iba1

1 reference

7 January 2021

CX3CL1 and CX3CR1 expression in human brain tissue: noninflammatory control versus multiple sclerosis

1 reference

7 January 2021

Molecular insights on the cerebral innate immune system

1 reference

7 January 2021

Disproportionate recruitment of CD8+ T cells into the central nervous system by professional antigen-presenting cells

1 reference

7 January 2021

Interleukin-1 and neuronal injury: mechanisms, modification, and therapeutic potential

1 reference

7 January 2021

Fractalkine modulates TNF-alpha secretion and neurotoxicity induced by microglial activation

1 reference

7 January 2021

Lack of involvement of neuronal nitric oxide synthase in the pathogenesis of a transgenic mouse model of familial amyotrophic lateral sclerosis.

1 reference

7 January 2021

Fractalkine cleavage from neuronal membranes represents an acute event in the inflammatory response to excitotoxic brain damage

1 reference

7 January 2021

Production and neuroprotective functions of fractalkine in the central nervous system

1 reference

7 January 2021

Mice deficient in fractalkine are less susceptible to cerebral ischemia-reperfusion injury

1 reference

7 January 2021

An initial investigation of spinal mechanisms underlying pain enhancement induced by fractalkine, a neuronally released chemokine

1 reference

7 January 2021

Evidence that exogenous and endogenous fractalkine can induce spinal nociceptive facilitation in rats.

1 reference

7 January 2021

Down-regulation of the macrophage lineage through interaction with OX2 (CD200)

1 reference

7 January 2021

Lymphoid/neuronal cell surface OX2 glycoprotein recognizes a novel receptor on macrophages implicated in the control of their function

1 reference

7 January 2021

Decreased atherosclerosis in CX3CR1-/- mice reveals a role for fractalkine in atherogenesis

1 reference

7 January 2021

The disintegrin-like metalloproteinase ADAM10 is involved in constitutive cleavage of CX3CL1 (fractalkine) and regulates CX3CL1-mediated cell-cell adhesion

1 reference

7 January 2021

The fractalkine receptor CX3CR1 is a key mediator of atherogenesis

1 reference

7 January 2021

Association between polymorphism in the chemokine receptor CX3CR1 and coronary vascular endothelial dysfunction and atherosclerosis

1 reference

7 January 2021

The many roles of chemokines and chemokine receptors in inflammation

1 reference

7 January 2021

1 reference

7 January 2021

New stereological methods for counting neurons

1 reference

7 January 2021

Effects of cardiotrophin-1 (CT-1) in a mouse motor neuron disease

1 reference

7 January 2021